Minerva Neurosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -625.7% | -625.7% | -64.7% |
| FY2022 | 160.3% | 160.3% | -58.3% |
| FY2023 | 105.4% | 105.4% | -52.7% |
| FY2024 | -5.6% | -5.6% | 3.9% |
| FY2025 | 208.5% | 208.5% | -299.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -625.7% | -625.7% | -64.7% |
| FY2022 | 160.3% | 160.3% | -58.3% |
| FY2023 | 105.4% | 105.4% | -52.7% |
| FY2024 | -5.6% | -5.6% | 3.9% |
| FY2025 | 208.5% | 208.5% | -299.5% |